Abstract
Friedreich’s ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by decreased expression of the protein Frataxin. Frataxin deficiency leads to excessive free radical production and dysfunction of chain complexes. Mitochondrial DNA (mtDNA) could be considered a candidate modifier factor for FRDA disease, since mitochondrial oxidative stress is thought to be involved in the pathogenesis of this disease. It prompted us to focus on the mtDNA and monitor the nucleotide changes of genome which are probably the cause of respiratory chain defects and reduced ATP generation. We searched about 46% of the entire mitochondrial genome by temporal temperature gradient gel electrophoresis (TTGE) and DNA fragments showing abnormal banding patterns were sequenced for the identification of exact mutations. In 18 patients, for the first time, we detected 26 mtDNA mutations; of which 5 (19.2%) was novel and 21 (80.8%) have been reported in other diseases. Heteroplasmic C13806A polymorphisms were associated with Iranian FRDA patients (55.5%). Our results showed that NADH dehydrogenase (ND) genes mutations in FRDA samples were higher than normal controls (P < 0.001) and we found statistically significant inverse correlation (r = −0.8) between number of mutation in ND genes and age of onset in FRDA patients. It is possible that mutations in ND genes could constitute a predisposing factor which in combination with environmental risk factors affects age of onset and disease progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson S, Bankier AT, Barrel BG et al (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457–465. doi:10.1038/290457a0
Babcock M, de Silva D, Oaks R et al (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276:1709–1712. doi:10.1126/science.276.5319.1709
Bradley J, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AHV (2000) Clinical, biochemical and molecular genetic correlations in Friedreich’s ataxia. Hum Mol Genet 9(2):275–282. doi:10.1093/hmg/9.2.275
Campuzano V, Monermini L, Molto MD, Pianese L, Cossee M (1996) Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423–1427. doi:10.1126/science.271.5254.1423
Cooper JM, Mann VM, Krige D, Schapira AHV (1992) Human mitochondrial complex I dysfunction. Biochim Biophys Acta 1101:198–203. doi:10.1016/S0005-2728(05)80019-2
Cossi M, Schmitt M, Campuzano V (1997) Evolution of the Friedreich’s ataxia trinucleotide repeat expansions: founder effect and permutations. Proc Natl Acad Sci USA 94:7452–7457. doi:10.1073/pnas.94.14.7452
Foury F, Cazzalini O (1997) Deletion of the yeast homologue of the human gene associated with Friedreich’s ataxia elicits iron accumulation in mitochondria. FEBS Lett 411:373–377. doi:10.1016/S0014-5793(97)00734-5
Foury F, Talibi D (2001) Mitochondrial control of iron homeostasis. A genome wide analysis of gene expression in a yeast frataxin deficient mutant. J Biol Chem 276:7762–7768. doi:10.1074/jbc.M005804200
Geffroy G, Barbeau A, Breton G (1976) Clinical description and roentgenologic evaluation of patients with Friedreich’s ataxia. Can J Neurol Sci 3:279–286
Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104:589–620. doi:10.1093/brain/104.3.589
Heales SJR, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB (1999) Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410:215–228. doi:10.1016/S0005-2728(98)00168-6
Houshmand M, Shariat Panahi SM, Nafisi S, Soltanzadeh A, Alkandari FM (2006) Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich’s ataxia. Mitochondrion 6:87–93
Johns DR, Berman J (1991) Alternative, simultaneous complex I mitochondrial DNA mutations in Leber’s hereditary optic neuropathy. Biochem Biophys Res Commun 174:1324–1330. doi:10.1016/0006-291X(91)91567-V
Kish SJ, Bergeron C, Rajput A, Dozic S, Masdrogiacomo F, Chang L (1992) Brain cytochrome oxidase in Alzheimers disease. J Neurochem 59:776–779. doi:10.1111/j.1471-4159.1992.tb09439.x
Lu F, Selak M, O’Connor J et al (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in lesions of multiple sclerosis. J Neurol Sci 177:95–103. doi:10.1016/S0022-510X(00)00343-9
MtDB—Human Mitochondrial Genome Database (2008) http://www.genpat.uu.se/mtDB/
Ramazzotti A, Vanmansart V, Foury F (2004) Mitochondrial functional interactions between frataxin and Isu1p, the iron-sulfur cluster scaffold protein, in Saccharomyces cerevisiae. FEBS Lett 557:215–220. doi:10.1016/S0014-5793(03)01498-4
Rotig A, de Lonlay P, Chretien D et al (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17:215–217. doi:10.1038/ng1097-215
Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinsons disease. J Neurochem 54:823–827. doi:10.1111/j.1471-4159.1990.tb02325.x
Tan DJ, Bai RK, Wong LJC (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62:972–976
Wallace DC, Lott MT, Brown MD, Kerstann K (2001) Mitochondria and neuro-ophthalmologic diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2425–2509
Wei YH (1998) Oxidative stress and mtDNA mutations in human evolution and disease. Proc Natl Acad Sci USA 217:53–63
Wilson RB, Roof DM (1997) Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet 16:352–357. doi:10.1038/ng0897-352
Wong LJC, Liang MH, Kwon H, Park J, Bai RK, Tan DJ (2002) Comprehensive scanning of the entire mitochondrial genome for mutations. Clin Chem 48:1901–1912
Acknowledgments
This research was supported by Tarbiat Modares University (TMU). We thank all patients for providing blood samples for scientific research as well as Special Medical Center (Tehran, Iran), whose cooperation and support is essential in our work. The study was approved by National Institute for Genetic Engineering and Biotechnology (NIGEB) Human Research Ethics committee.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heidari, M.M., Houshmand, M., Hosseinkhani, S. et al. A Novel Mitochondrial Heteroplasmic C13806A Point Mutation Associated with Iranian Friedreich’s Ataxia. Cell Mol Neurobiol 29, 225–233 (2009). https://doi.org/10.1007/s10571-008-9315-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-008-9315-9